Archives for May 11, 2006

← 2006

Trio of Applied Biosystems' products debut at Analytica

By  Wai Lang Chu

Fresh from its recent acquisition, Applied Biosystems (AB) made an appearance at the recent Analytica show in which the company demonstrated the capabilities of its products for life science research in the laboratory.

Abbott 'didn't monitor all components' for hazardous air pollutants

By  Gregory Roumeliotis

Abbott Laboratories has reached a settlement with the US Environmental Protection Agency (EPA) after it was found not complying with leak detection and repair (LDAR) requirements for hazardous air pollutants at its manufacturing plant in North Chicago.

Biogeneric race in Europe heats up

By  Gregory Roumeliotis

Swiss biopharmaceutical firm Biopartners has got the thumbs up from the European Commission for its biosimilar drug Valtropin, making it only the second biogeneric drug to have been approved in Europe after Sandoz's Omnitrope received marketing...

DSM's cost cuts pay off

By  Gregory Roumeliotis

Chemicals and nutrition group DSM has reported strong profits for the first quarter in 2006, including in its pharma business, as higher prices and lower costs have helped it overcome the increase in raw material costs.

FDA moves to make prescription drug labelling info more accessible

By  Wai Lang Chu

The move to make pharmaceutical companies more open to scrutiny has taken a new direction as the US Food and Drug Administration (FDA) moves to adopt a system that will allow the electronic coding of crucial terms used in prescription drug labelling.

Unique pumps improve chemical manufacturing process

By Wai Lang Chu

A new range of liquid pumps, which feature completely inert pumping heads, are causing waves within the chemical manufacturing industry, with the ability to mimic full scale production plant conditions in a laboratory environment.